CHEMED CORP 8-K

What Happened
Chemed Corp (CHE) filed an 8-K on May 19, 2026 reporting the results of its annual meeting. All nine director nominees were elected. Shareholders ratified the appointment of PricewaterhouseCoopers LLP as the company’s independent accountants for the year ending December 31, 2026. The advisory "say‑on‑pay" vote on executive compensation was not approved.

Key Details

• Meeting filed via 8-K on May 19, 2026. Broker non‑votes for director elections: 769,580.
• Directors elected (For / Against / Abstain):
  • Kevin J. McNamara: 11,111,578 / 204,388 / 6,735
  • Ron DeLyons: 11,252,597 / 62,247 / 7,858
  • Patrick P. Grace: 9,368,923 / 1,946,697 / 7,082
  • Christopher J. Heaney: 10,891,279 / 424,319 / 7,104
  • Thomas C. Hutton: 11,053,081 / 262,174 / 7,447
  • Andrea R. Lindell: 10,642,996 / 672,859 / 6,847
  • Elaine McCarthy: 11,173,021 / 141,697 / 7,984
  • John M. Mount Jr.: 11,245,765 / 69,479 / 7,458
  • George J. Walsh III: 10,007,160 / 1,308,559 / 6,983
• Auditor ratification: PricewaterhouseCoopers LLP approved — For 11,562,294; Against 523,129; Abstain 6,858.
• Executive compensation (say‑on‑pay) — NOT approved (advisory): For 4,383,683; Against 6,926,656; Abstain 12,363; Broker non‑votes 769,580.

Why It Matters
The filing records formal shareholder outcomes: the board remains in place after re‑election of all nominees and PwC is confirmed as auditor for 2026. The failure of the advisory say‑on‑pay vote indicates a majority of voting shareholders opposed the company's executive compensation package at this meeting; the vote is non‑binding but is a clear, documented shareholder sentiment that the company will disclose and consider in its corporate governance communications.